Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Inman

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Acta Medica Scandinavica. Supplementum|January 1, 1984
Prescription-event monitoring. A preliminary study of benoxaprofen and fenbufenW H Inman
Lancet (London, England)|June 9, 1984
Prescription-event monitoring and yellow cardsW H Inman
Journal of Clinical Epidemiology|January 1, 1988
Beyond pharmacoepidemiologyW H Inman
European Journal of Rheumatology and Inflammation|January 1, 1987
Non-steroidal anti-inflammatory drugs: assessment of risksW H Inman
European Journal of Clinical Pharmacology|January 1, 1994
Terminology in prescription-event monitoringK Kubota, W H Inman
Lancet (London, England)|December 11, 1993
Prescriber profile and postmarketing surveillanceW H Inman, G Pearce
British Medical Journal|November 25, 1978
Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of MedicinesW H Inman, W W Mushin
Medical Toxicology|January 1, 1986
Prescription-Event Monitoring. Recent experience with 5 NSAIDsN S Rawson, W H Inman
British Medical Journal (Clinical Research Ed.)|June 18, 1983
Erythromycin estolate and jaundiceW H Inman, N S Rawson
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1985
Stimulation of glucose uptake by transforming growth factor beta: evidence for the requirement of epidermal growth factor-receptor activationW H Inman, S P Colowick
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Acta Medica Scandinavica. Supplementum|January 1, 1984
Prescription-event monitoring. A preliminary study of benoxaprofen and fenbufenW H Inman
Lancet (London, England)|June 9, 1984
Prescription-event monitoring and yellow cardsW H Inman
Journal of Clinical Epidemiology|January 1, 1988
Beyond pharmacoepidemiologyW H Inman
European Journal of Rheumatology and Inflammation|January 1, 1987
Non-steroidal anti-inflammatory drugs: assessment of risksW H Inman
European Journal of Clinical Pharmacology|January 1, 1994
Terminology in prescription-event monitoringK Kubota, W H Inman
Lancet (London, England)|December 11, 1993
Prescriber profile and postmarketing surveillanceW H Inman, G Pearce
British Medical Journal|November 25, 1978
Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of MedicinesW H Inman, W W Mushin
Medical Toxicology|January 1, 1986
Prescription-Event Monitoring. Recent experience with 5 NSAIDsN S Rawson, W H Inman
British Medical Journal (Clinical Research Ed.)|June 18, 1983
Erythromycin estolate and jaundiceW H Inman, N S Rawson
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1985
Stimulation of glucose uptake by transforming growth factor beta: evidence for the requirement of epidermal growth factor-receptor activationW H Inman, S P Colowick
Pageof 6